Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2177)
All Articles published online
|
Sep 21, 2009 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Prantera C, Rizzi M. 5-ASA in ulcerative colitis: Improving treatment compliance. World J Gastroenterol 2009; 15(35): 4353-4355 [PMID: 19764084 DOI: 10.3748/wjg.15.4353] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i35/4353.htm |
| Number | Citing Articles |
| 1 |
Radan Keil, Martin Wasserbauer, Zdena Zádorová, Vladimír Kojecký, Štěpán Hlava, Jan Št’ovíček, Jakub Chudý, Markéta Roznětinská, Jiří Drábek, Nikola Kubišová, Jindra Lochmannová. Adherence, risk factors of non-adherence and patient’s preferred treatment strategy of mesalazine in ulcerative colitis: multicentric observational study. Scandinavian Journal of Gastroenterology 2018; 53(4): 459 doi: 10.1080/00365521.2018.1451915
|
| 2 |
P. Frei, G. Rogler. Topische Therapie bei chronisch-entzündlichen Darmerkrankungen. coloproctology 2014; 36(5): 353 doi: 10.1007/s00053-014-0468-3
|
| 3 |
Tereza Bautzová, Miloslava Rabišková, Alf Lamprecht. Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease. Drug Development and Industrial Pharmacy 2011; 37(9): 1100 doi: 10.3109/03639045.2011.560156
|
| 4 |
Michael Stephens, Alisha M. Mavis. Pediatric Inflammatory Bowel Disease. 2013; : 281 doi: 10.1007/978-1-4614-5061-0_26
|
| 5 |
Christopher S.J. Probert, Axel U. Dignass, Stefan Lindgren, Marco Oudkerk Pool, Philippe Marteau. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: Rapid symptom resolution and improvements in quality of life. Journal of Crohn's and Colitis 2014; 8(3): 200 doi: 10.1016/j.crohns.2013.08.007
|
| 6 |
Dae-Seung Kim, Sung-Hee Kim, Ji-Ye Kee, Yo-Han Han, JinBong Park, Jeong-Geon Mun, Moon-Jung Joo, Yong-Deok Jeon, Su-Jin Kim, Sang-Hyun Park, Sung-Joo Park, Jae-Young Um, Seung-Heon Hong. Eclipta prostrataImproves DSS-Induced Colitis through Regulation of Inflammatory Response in Intestinal Epithelial Cells. The American Journal of Chinese Medicine 2017; 45(05): 1047 doi: 10.1142/S0192415X17500562
|
| 7 |
Yan-cheng Dai, Zhi-peng Tang, Zhen-nan Wang, Ya-li Zhang, Xin-ying He. Influence of Shenqing Recipe on Morphology and Quantity of Colonic Interstitial Cells of Cajal in Trinitrobenzene Sulfonic Acid Induced Rat Colitis. Chinese Medical Sciences Journal 2011; 26(1): 43 doi: 10.1016/S1001-9294(11)60018-7
|
| 8 |
Sneha Annie Sebastian, Oroshay Kaiwan, Edzel L. Co, Meghana Mehendale, Babu P. Mohan. Current Pharmacologic Options and Emerging Therapeutic Approaches for the Management of Ulcerative Colitis: A Narrative Review. Spartan Medical Research Journal 2024; 9(3) doi: 10.51894/001c.123397
|
| 9 |
H. Ueyama, KI. Fu, K. Ogura, S. Murata, A. Miyazaki. Successful treatment for Cronkhite-Canada syndrome with endoscopic mucosal resection and salazosulfapyridine. Techniques in Coloproctology 2014; 18(5): 503 doi: 10.1007/s10151-012-0863-0
|
| 10 |
Salam F. Zakko, Glenn L. Gordon, Uma Murthy, Shahriar Sedghi, Ronald Pruitt, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes, Gary R. Lichtenstein. Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors. Postgraduate Medicine 2016; 128(3): 273 doi: 10.1080/00325481.2016.1152876
|
| 11 |
Michelle Gonzalez, Michael Stephens. Pediatric Inflammatory Bowel Disease. 2023; : 339 doi: 10.1007/978-3-031-14744-9_25
|
| 12 |
Gary R. Lichtenstein, Andrew C. Barrett, Enoch Bortey, Craig Paterson, William P. Forbes. Long-term Safety and Tolerability of Once-daily Mesalamine Granules in the Maintenance of Remission of Ulcerative Colitis. Inflammatory Bowel Diseases 2014; 20(8): 1399 doi: 10.1097/MIB.0000000000000076
|
| 13 |
El Bethel Lalthavel Hmar, Sujata Paul, Nayanmoni Boruah, Priyanka Sarkar, Sudarshana Borah, Hemanta Kumar Sharma. Apprehending Ulcerative Colitis Management With Springing Up Therapeutic Approaches: Can Nanotechnology Play a Nascent Role?. Current Pathobiology Reports 2021; 9(1): 9 doi: 10.1007/s40139-020-00218-6
|
| 14 |
Yi Zhou, Xinyu Xiong, Zhe Cheng, Zekai Chen, Shizhen Wu, Yan Yu, Yujin Liu, Guang Chen, Lingli Li. Ginsenoside Rb1 Alleviates DSS-Induced Ulcerative Colitis by Protecting the Intestinal Barrier Through the Signal Network of VDR, PPARγ and NF-κB. Drug Design, Development and Therapy 2024; : 4825 doi: 10.2147/DDDT.S481769
|
| 15 |
Chien Nguyen, J. Mark Christensen, James W. Ayres. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon. Pharmaceutical Development and Technology 2012; 17(1): 73 doi: 10.3109/10837450.2010.516436
|
| 16 |
Jinyi Zhai, Julia Mantaj, Driton Vllasaliu. Ascorbyl Palmitate Hydrogel for Local, Intestinal Delivery of Macromolecules. Pharmaceutics 2018; 10(4): 188 doi: 10.3390/pharmaceutics10040188
|
| 17 |
S. P. L. Travis, P. D. R. Higgins, T. Orchard, C. J. Van Der Woude, R. Panaccione, A. Bitton, C. O’Morain, J. Panés, A. Sturm, W. Reinisch, M. A. Kamm, G. D’Haens. Review article: defining remission in ulcerative colitis. Alimentary Pharmacology & Therapeutics 2011; 34(2): 113 doi: 10.1111/j.1365-2036.2011.04701.x
|
| 18 |
Michael Stephens, Michelle Gonzalez. Pediatric Inflammatory Bowel Disease. 2017; : 317 doi: 10.1007/978-3-319-49215-5_25
|
| 19 |
Yun-Chu Chen, Sheryhan F. Gad, Dhawal Chobisa, Yongzhe Li, Yoon Yeo. Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities. Journal of Controlled Release 2021; 330: 438 doi: 10.1016/j.jconrel.2020.12.025
|
| 20 |
Sidhartha R. Sinha, Linh P. Nguyen, Mohammed Inayathullah, Andrey Malkovskiy, Frezghi Habte, Jayakumar Rajadas, Aida Habtezion. A Thermo-Sensitive Delivery Platform for Topical Administration of Inflammatory Bowel Disease Therapies. Gastroenterology 2015; 149(1): 52 doi: 10.1053/j.gastro.2015.04.002
|
| 21 |
Bryan L Love, April D Miller. Extended-Release Mesalamine Granules for Ulcerative Colitis. Annals of Pharmacotherapy 2012; 46(11): 1529 doi: 10.1345/aph.1R171
|
| 22 |
P. Frei, G. Rogler. Topische Therapie bei chronisch-entzündlichen Darmerkrankungen. Der Gastroenterologe 2013; 8(3): 197 doi: 10.1007/s11377-012-0724-4
|
| 23 |
F. Seibold, N. Fournier, C. Beglinger, C. Mottet, V. Pittet, G. Rogler. Topical therapy is underused in patients with ulcerative colitis. Journal of Crohn's and Colitis 2014; 8(1): 56 doi: 10.1016/j.crohns.2013.03.005
|
| 24 |
Andreea Aprodu, Julia Mantaj, Bahijja Raimi-Abraham, Driton Vllasaliu. Evaluation of a Methylcellulose and Hyaluronic Acid Hydrogel as a Vehicle for Rectal Delivery of Biologics. Pharmaceutics 2019; 11(3): 127 doi: 10.3390/pharmaceutics11030127
|
| 25 |
Oghenewoma P. Oghenesume, Michael J. Gouzoulis, Philip P. Ratnasamy, Meera M. Dhodapkar, Jonathan N. Grauer, Lee E. Rubin. Ulcerative Colitis Patients are at Increased Risk for Adverse Events Following Total Hip Arthroplasty. The Journal of Arthroplasty 2024; doi: 10.1016/j.arth.2024.10.134
|